Discontinued — last reported Q2 '23
Procter & Gamble Health Care — Restructuring Charges remained flat by 0.0% to $7.00M in Q2 2023 compared to the prior quarter. Year-over-year, this metric declined by 12.5%, from $8.00M to $7.00M. Over 2 years (FY 2021 to FY 2023), Health Care — Restructuring Charges shows a downward trend with a -25.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High charges indicate significant organizational change, which may temporarily depress earnings but often aims to improve future profitability.
These are costs incurred to reorganize the Health Care segment's operations, which may include severance, facility closu...
Comparable to restructuring or impairment charges reported by peers undergoing operational transformation or cost-saving initiatives.
pg_segment_health_care_restructuring_charges| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $51.00M | $32.00M | $28.00M |
| YoY Change | — | -37.3% | -12.5% |